Key terms
About CNMD
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CNMD news
Feb 21
7:25am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 21
4:55am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 15
12:57pm ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 01
10:00am ET
Conmed falls -12.3%
Feb 01
9:47am ET
Conmed falls -12.2%
Feb 01
8:56am ET
Conmed price target lowered to $100 from $130 at Piper Sandler
Feb 01
8:21am ET
Conmed price target lowered to $110 from $120 at Stifel
Feb 01
8:10am ET
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Thermo Fisher (TMO) and Align Tech (ALGN)
Feb 01
8:07am ET
Piper Sandler Reaffirms Their Buy Rating on Conmed (CNMD)
Feb 01
7:16am ET
Conmed Performance Review: Hold Rating with Cautious Growth and Margin Outlook
Feb 01
7:10am ET
Conmed price target lowered to $98 from $107 at Wells Fargo
Feb 01
6:41am ET
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Roche Holding AG (OtherRHHVF) and Sanofi (OtherSNYNF)
Jan 31
4:10pm ET
Conmed sees FY24 adjusted EPS $4.30-$4.40, consensus $4.40
Jan 31
4:09pm ET
Conmed reports Q4 adjusted EPS $1.06, consensus $1.11
Jan 25
5:47am ET
Hold Rating on Conmed Amid Competitive Pressures and Growth Uncertainties
Jan 05
8:00am ET
Analysts Are Bullish on These Healthcare Stocks: Conmed (CNMD), Illumina (ILMN)
Dec 13
7:57am ET
Wells Fargo Remains a Hold on Conmed (CNMD)
No recent press releases are available for CNMD
CNMD Financials
Key terms
Ad Feedback
CNMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CNMD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range